Case Report
Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism
Table 1
Antiphospholipid profile at the time of presentation and at twelve-week follow-up.
| Tests | At presentation (normal) | Three months after (normal) |
| Anticardiolipin IgG | 140 (<15 GPL units) | 135 | Anticardiolipin IgM | 30.4 (<12.5 MPL units) | 60.6 | Anti-β2 glycoprotein 1 IgG | >150 (<20 SGU) | >150 | Anti-β2 glycoprotein 1 IgM | 38 (<20 SMU) | 42 | PTT, lupus sensitive | 82.5 (32–45 s) | | DRVVT screen | 69.1 (31.4–45 s) | | DRVVT confirmation | 1.6 (<1.3 s) | | Hexagonal phase phospholipid | 39.7 (0–8 s) | |
|
|